| Website | orega-biotech.com |
| Category | BioTech |
| Phone | +33 (0) 4 37 49 87 20 |
| Employees |
| TOTAL | $3.71M |
| FUNDING TOTAL | $3.71M |
| Venture Round, 9/10 Octalfa | $3.71M |
BIO-TECH OREGA Is A biotech company Committed To The Development of Immunotherapeutics for innovative cancer. Backed by INSERM-Transfert and OCTALFA , OREGA-BIOTECH was set up in March 2010 at the initiative of its four founders bringing together scientific and business skills. Gilles Alberici (PharmD, PhD), with more than 20-year experience in the pharmaceutical industry and biotech start-ups, is the President. OREGA-BIOTECH is based on the research conducted by the other founders, Nathalie Bonnefoy-Berard (PhD) and Armand Bensussan (PhD), Research Directors at the INSERM units 851 (Lyon) and 976 (Paris) respectively, and Jean-François Eliaou (MD, PhD), Professor of Medicine and Head of the Department of Immunology at the University Hospital of Montpellier.
